Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Anti-rheumatic drugs

Identifieur interne : 003779 ( Main/Exploration ); précédent : 003778; suivant : 003780

Anti-rheumatic drugs

Auteurs : T. R. Littler [Royaume-Uni]

Source :

RBID : ISTEX:2EFAD243EEB9B9184B35ED00A9D693C0BB876C62

English descriptors


Url:
DOI: 10.1016/0163-7258(81)90015-2


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Anti-rheumatic drugs</title>
<author>
<name sortKey="Littler, T R" sort="Littler, T R" uniqKey="Littler T" first="T. R." last="Littler">T. R. Littler</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2EFAD243EEB9B9184B35ED00A9D693C0BB876C62</idno>
<date when="1981" year="1981">1981</date>
<idno type="doi">10.1016/0163-7258(81)90015-2</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-ZGP17PJP-J/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000120</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000120</idno>
<idno type="wicri:Area/Istex/Curation">000120</idno>
<idno type="wicri:Area/Istex/Checkpoint">002537</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002537</idno>
<idno type="wicri:doubleKey">0163-7258:1981:Littler T:anti:rheumatic:drugs</idno>
<idno type="wicri:Area/Main/Merge">003858</idno>
<idno type="wicri:Area/Main/Curation">003779</idno>
<idno type="wicri:Area/Main/Exploration">003779</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Anti-rheumatic drugs</title>
<author>
<name sortKey="Littler, T R" sort="Littler, T R" uniqKey="Littler T" first="T. R." last="Littler">T. R. Littler</name>
<affiliation wicri:level="2">
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>University of Liverpool and Leasowe Hospital Rheumatology Unit, Liverpool L69 3BX, Merseyside</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Pharmacology and Therapeutics</title>
<title level="j" type="abbrev">JPT</title>
<idno type="ISSN">0163-7258</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1981">1981</date>
<biblScope unit="volume">15</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="45">45</biblScope>
<biblScope unit="page" to="68">68</biblScope>
</imprint>
<idno type="ISSN">0163-7258</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0163-7258</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Abnormality</term>
<term>Adjuvant arthritis</term>
<term>Adverse reactions</term>
<term>Ankylosing spondylitis</term>
<term>Ansell</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Arthropathy</term>
<term>Aurothiomalate</term>
<term>Azathioprine</term>
<term>Beneficial effect</term>
<term>Benoxaprofen</term>
<term>Bone marrow</term>
<term>Cessation</term>
<term>Chloroquine</term>
<term>Chrysotherapy</term>
<term>Clinical improvement</term>
<term>Clinical response</term>
<term>Clinical trials</term>
<term>Clinician</term>
<term>Clozic</term>
<term>Corticosteroid</term>
<term>Corticosteroid drugs</term>
<term>Corticosteroid preparations</term>
<term>Corticosteroid therapy</term>
<term>Corticotrophin</term>
<term>Crockson</term>
<term>Cutaneous</term>
<term>Cutaneous vasculitis</term>
<term>Cyclophosphamide</term>
<term>Dapsone</term>
<term>Dermatitis herpetiformis</term>
<term>Disease activity</term>
<term>Dos</term>
<term>Dosage</term>
<term>Drug treatment</term>
<term>Early cases</term>
<term>Early stages</term>
<term>Erythematosus</term>
<term>Erythrocyte sedimentation rate</term>
<term>Eular</term>
<term>Eular publishers</term>
<term>Excellent reviews</term>
<term>Favorable results</term>
<term>Fenclofenac</term>
<term>General health</term>
<term>Gold salts</term>
<term>Gold therapy</term>
<term>Guide lines</term>
<term>Hemoglobin level</term>
<term>Huskisson</term>
<term>Hydroxychloroquine</term>
<term>Immune</term>
<term>Immune system</term>
<term>Intramuscular</term>
<term>Knee joints</term>
<term>Lancet</term>
<term>Levamisole</term>
<term>Littler</term>
<term>Lupus</term>
<term>Lupus erythematosus</term>
<term>Maintenance dose</term>
<term>Malignant disease</term>
<term>Many years</term>
<term>Mcconkey</term>
<term>Mowat</term>
<term>Mucosal surfaces</term>
<term>Multicentre</term>
<term>Myasthenia gravis</term>
<term>Palindromic arthritis</term>
<term>Patient compliance</term>
<term>Penicillamine</term>
<term>Penicillamine therapy</term>
<term>Polyarthritis</term>
<term>Prednisolone</term>
<term>Prostaglandin</term>
<term>Prostaglandin synthesis</term>
<term>Psoriatic arthropathy</term>
<term>Radiographic progression</term>
<term>Rash</term>
<term>Remission</term>
<term>Rheum</term>
<term>Rheumatic</term>
<term>Rheumatic disease</term>
<term>Rheumatic diseases</term>
<term>Rheumatic polyarthritis</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatoid disease</term>
<term>Rheumatoid factor</term>
<term>Rheumatoid factor titres</term>
<term>Rheumatol</term>
<term>Rheumatological practice</term>
<term>Same reason</term>
<term>Saunders</term>
<term>Side effects</term>
<term>Significant reduction</term>
<term>Sodium aurothiomalate</term>
<term>Steroid</term>
<term>Steroid therapy</term>
<term>Strength tablets</term>
<term>Subjective improvement</term>
<term>Such cases</term>
<term>Such circumstances</term>
<term>Suppl</term>
<term>Systemic lupus erythematosus</term>
<term>Therapy</term>
<term>Ulceration</term>
<term>Whilst</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
</region>
</list>
<tree>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Littler, T R" sort="Littler, T R" uniqKey="Littler T" first="T. R." last="Littler">T. R. Littler</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003779 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003779 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:2EFAD243EEB9B9184B35ED00A9D693C0BB876C62
   |texte=   Anti-rheumatic drugs
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021